NuVasive initiated at UBS

NuVasive initiated with a Sell at UBS. UBS analyst Matthew Taylor initiated with a Sell rating and $54 price target, calling the stock a Top Sell. Taylor believes that “challenging competitive and market dynamics will continue to anchor growth” and that lack of robotics and big new product cycles will “dampen ability to add reps and customers.”

https://thefly.com/landingPageNews.php?id=2828764